Yu Han

发表

Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study

Y. Ba, Jianming Xu, T. Deng, 2013, Medical Oncology.

Apatinib with etoposide capsules as a third- or further-line therapy for extensive-stage small cell lung cancer: an open-label, multicenter, single-arm phase II trial

Xudong Zhang, Qiming Wang, Tianjiang Ma, 2021, Translational lung cancer research.

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors

G. Curigliano, J. Rodon, D. Sellami, 2018, Oncotarget.

Epidermal growth factor receptor mutations , HER 2 / 3 protein expressions and clinical outcome in the Chinese patients with advanced non small cell lung cancer treated with gefitinib

Yu Han, Yang Zhang, J. Xu, 2010 .

Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer

A. Paradiso, Chuan-hua Zhao, Yan Wang, 2006, BMC Cancer.

EPIK-O/ENGOT-OV61: Alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study).

Jae-Weon Kim, B. Monk, R. Glasspool, 2022, Future oncology.

Nude mice multi-drug resistance model of orthotopic transplantation of liver neoplasm and Tc-99m MIBI SPECT on p-glycoprotein.

Hong Zhu, Zhiyong Huang, Xiao-ping Chen, 2005, World journal of gastroenterology.

EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib

A. Paradiso, Yang Zhang, D. Galetta, 2009, Journal of Cancer Research and Clinical Oncology.

Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2− Advanced Breast Cancer

A. Bardia, M. Campone, L. Dirix, 2020, Clinical Cancer Research.

Targeting adenovirus to CD 80 and CD 86 receptors increases gene transfer efficiency to malignant glioma cells

Rivera, Ilya, Zhu, 2007 .

Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer.

Xingsong Tian, Guangchao Jin, Cun Liu, 2015, International journal of clinical and experimental pathology.

Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer

T. Ishikawa, J. Chiu, N. Masuda, 2020, Cancer science.

EGFR / HER2 / HER3 expression in tumour and gefitinib treatment in Chinese patients with advanced non-small cell lung cancer

A. Paradiso, Jianming Xu, Yu Han, 2008 .